13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study

Published:2015-03-23 Issue:8 Volume:62 Page:1427-1436
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

De Montalembert Mariane¹,Abboud Miguel R.²,Fiquet Anne³,Inati Adlette⁴,Lebensburger Jeffrey D.⁵,Kaddah Normeen⁶,Mokhtar Galila⁷,Piga Antonio⁸,Halasa Natasha⁹,Inusa Baba¹⁰,Rees David C.¹¹,Heath Paul T.¹²,Telfer Paul¹³,Driscoll Catherine¹⁴,Al Hajjar Sami¹⁵,Tozzi Alberto¹⁶,Jiang Qin¹⁷,Emini Emilio A.¹⁸,Gruber William C.¹⁸,Gurtman Alejandra¹⁸,Scott Daniel A.¹⁸

Affiliation:

1. Hôpital Necker-Enfants Malades; Service de Pédiatrie; Paris France

2. Department of Pediatrics and Adolescent Medicine; American University of Beirut; Beirut Lebanon

3. Vaccine Research; Pfizer Ltd; Tadworth Berkshire UK

4. RHUH; Rafic Hariri University Hospital; Beirut Lebanon

5. University of Alabama at Birmingham; Birmingham; Alabama

6. Pediatric Cairo University Hospital (Abu Elreesh - Almoneera); Egypt

7. Hematology unit; Children Hospital; Ain Shams University; Cairo Egypt

8. Ospedale San Luigi Gonzaga; Orbassano; Torino University; Italy

9. Vanderbilt University Medical Center; Nashville Tennessee

10. Evelina Children's Hospital; St Thomas' Hospital; London UK

11. King's College Hospital; London UK

12. Vaccine Institute; St Georges; University of London; London UK

13. Royal London Hospital; London; UK

14. Children's Hospital at Montefiore; Bronx New York

15. King Faisal Specialist Hospital and Research Centre; Riyadh; Saudi Arabia

16. Unità Operativa di Epidemiologia Ospedale Bambino Gesù; Roma; Italy

17. Vaccines; Pfizer Inc; Collegeville Pennsylvania

18. Vaccine Research; Pfizer Inc; Pearl River New York

Funder

Pfizer Inc

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25502/fullpdf

Reference26 articles.

1. Sickle cell anemia and severe infections due to encapsulated bacteria;Pearson;J Infect Dis,1977

2. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease;Leikin;Pediatrics,1989

3. The Prophylactic Penicillin Study Group. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial;Gaston;N Engl J Med,1986

4. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease;Hirst;Cochrane Database Syst Rev,2012

5. Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002;Yanni;J Pediatr,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guarding Health: A Comprehensive Review of Nosocomial Infections in Sickle Cell Anemia, a Multifaceted Approach to Prevention;Cureus;2024-01-30

2. PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children;Expert Review of Vaccines;2023-12-20

3. Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines;Blood Advances;2023-11-03

4. Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study;Blood Advances;2023-02-03

5. Immunological Efficacy of Pneumococcal Vaccination Including the 13-Valent Pneumococcal Conjugate Vaccine in Adult Patients With Sickle Cell Disease: Results of the Randomized DREVAC Controlled Trial;Clinical Infectious Diseases;2023-01-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3